Liozon E - Search Results

1

Denizot Y, Fixe P, Liozon E, Brigaudeau C, Praloran V. Denizot Y, et al. Among authors: liozon e. Br J Haematol. 1995 Jul;90(3):731-2. doi: 10.1111/j.1365-2141.1995.tb05612.x. Br J Haematol. 1995. PMID: 7647020 No abstract available.

2

Serum interleukin-8 (IL-8) and IL-6 concentrations in patients with hematologic malignancies.

Denizot Y, Fixe P, Liozon E, Praloran V. Denizot Y, et al. Among authors: liozon e. Blood. 1996 May 1;87(9):4016-7. Blood. 1996. PMID: 8611738 Free article. No abstract available.

3

AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia.

Liozon E, Volkov L, Comte L, Trimoreau F, Pradelles P, Bordessoule D, Frindel E, Praloran V. Liozon E, et al. Br J Haematol. 1995 Apr;89(4):917-20. doi: 10.1111/j.1365-2141.1995.tb08438.x. Br J Haematol. 1995. PMID: 7772535

4

Serum macrophage colony-stimulating factor concentrations in patients with lymphoid and non-lymphoid hematologic malignancies.

Fixe P, Denizot Y, Liozon E, Bordessoule D, Praloran V. Fixe P, et al. Among authors: liozon e. Eur Cytokine Netw. 1995 Jul-Dec;6(4):217-8. Eur Cytokine Netw. 1995. PMID: 8789285 No abstract available.

5

Decreased levels of platelet-activating factor in blood of patients with lymphoid and nonlymphoid hematologic malignancies.

Denizot Y, Dupuis F, Trimoreau F, Praloran V, Liozon E. Denizot Y, et al. Among authors: liozon e. Blood. 1995 May 15;85(10):2992-3. Blood. 1995. PMID: 7742560 Free article. No abstract available.

6

Deletion of chromosome 20q associated with hypereosinophilic syndrome. A report of two cases.

Brigaudeau C, Liozon E, Bernard P, Trimoreau F, Bordessoule D, Praloran V. Brigaudeau C, et al. Among authors: liozon e. Cancer Genet Cytogenet. 1996 Mar;87(1):82-4. doi: 10.1016/0165-4608(95)00260-x. Cancer Genet Cytogenet. 1996. PMID: 8646749

7

Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature.

Liozon E, Brigaudeau C, Trimoreau F, Desangles F, Fermeaux V, Praloran V, Bordessoule D. Liozon E, et al. Hematol Cell Ther. 1997 Feb;39(1):11-8. doi: 10.1007/s00282-997-0011-x. Hematol Cell Ther. 1997. PMID: 9088933

8

No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis.

Denizot Y, Liozon E, Guglielmi L, Ly K, Soria P, Loustaud V, Vidal E, Jauberteau MO. Denizot Y, et al. Among authors: liozon e. Mediators Inflamm. 2003 Apr;12(2):101-5. doi: 10.1080/0962935031000097718. Mediators Inflamm. 2003. PMID: 12775360 Free PMC article.

9

Serum levels of a negative regulator of cell proliferation (AcSDKP) are increased in certain human haemopathies.

Liozon E, Pradelles P, Venot J, Rigaud M, Cransac M, Bordessoule D, Frindel E. Liozon E, et al. Leukemia. 1993 Jun;7(6):808-12. Leukemia. 1993. PMID: 8501976

10

Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay.

Pradelles P, Frobert Y, Créminon C, Liozon E, Massé A, Frindel E. Pradelles P, et al. Among authors: liozon e. Biochem Biophys Res Commun. 1990 Aug 16;170(3):986-93. doi: 10.1016/0006-291x(90)90489-a. Biochem Biophys Res Commun. 1990. PMID: 2202303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters